CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,991,980
- in 20 filings, $60.0M under 10b5-1 plans
Net −$59,991,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 82 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-08 | ANDERSON ELIZABETH M Director | Grant or award | +5,200 | 15,825 | ||
| 2023-06-08 | ANDERSON ELIZABETH M Director | Grant or award · Stock Option (Right to Buy) | +18,400 | 18,400 | ||
| 2023-06-08 | SCHMIDT ERIC THOMAS Director | Grant or award | +5,200 | 21,251 | ||
| 2023-06-08 | SCHMIDT ERIC THOMAS Director | Grant or award · Stock Option (Right to Buy) | +18,400 | 18,400 | ||
| 2023-06-08 | Patel Sushil Director | Grant or award | +5,200 | 15,700 | ||
| 2023-06-08 | Patel Sushil Director | Grant or award · Stock Option (Right to Buy) | +18,400 | 18,400 | ||
| 2023-06-08 | Kim Lorence H. Director | Grant or award | +5,200 | 65,700 | ||
| 2023-06-08 | Kim Lorence H. Director | Grant or award · Stock Option (Right to Buy) | +18,400 | 18,400 | ||
| 2023-03-17 | Horn Margaret A | Sale | −1,230 | $21.78 | $27K | 100,062 |
| 2023-03-17 | Anders Jack Chief Financial Officer | Sale | −665 | $21.78 | $14K | 55,233 |
| 2023-03-17 | Kelsey Stephen Michael | Sale | −1,230 | $21.78 | $27K | 326,369 |
| 2023-03-17 | Wang Xiaolin | Sale | −714 | $21.78 | $16K | 58,813 |
| 2023-03-10 | Schroeder Thilo Director | Purchase | +93,800 | $20.43 | $1.9M | 1,546,934 |
| 2023-03-10 | Schroeder Thilo Director | Purchase | +6,200 | $20.85 | $129K | 1,553,134 |
| 2023-03-07 | Schroeder Thilo Director | Purchase | +231,819 | $22.00 | $5.1M | 1,453,134 |
| 2023-03-07 | Schroeder Thilo Director | Purchase | +318,181 | $22.00 | $7.0M | 618,181 |
| 2023-03-01 | Anders Jack Chief Financial Officer | Grant or award | +26,600 | 55,898 | ||
| 2023-03-01 | Anders Jack Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +93,100 | 93,100 | ||
| 2023-03-01 | Wang Xiaolin | Grant or award | +29,000 | 59,527 | ||
| 2023-03-01 | Wang Xiaolin | Grant or award · Stock Option (Right to Buy) | +101,500 | 101,500 |
Page 33 of 39 · 775 trades